Abstract
Purpose
There are no data regarding the actual need for fertility preservation (FP) in breast cancer (BC) patients. Our study provides a practical needs assessment for reproductive medicine by analyzing an unselected cohort of young BC patients. This assessment considers oncological factors as well as the patient’s obstetrical and gynecological history and reproductive outcome after BC diagnosis. We aimed to identify how many patients are actually potential candidates for FP and how many patients might consequently use their cryopreserved gametes to achieve pregnancy.
Methods
Based on a prospective BC database, we analyzed all patients who were ≤40 years at initial diagnosis (time period of diagnosis: 1990–2007; n = 100; 7.7 % of the entire BC cohort; median age: 35.9 years).
Results
Using an algorithm of exclusion criteria considering disease-specific, therapy-specific and family history characteristics, 36 patients who received chemotherapy were identified as potential “classical” candidates for FP. After 5 years, 22 women were identified as potential candidates for using their cryopreserved gametes to achieve pregnancy; the majority of these patients were childless (n = 16, 72.7 %) and in their late reproductive years (n = 12, 54.5 %).
Conclusions
Our study demonstrates that in a cohort of young BC patients only a minority of women are candidates for FP. Young BC patients who wish to have children in the future usually carry risk factors both from oncological and reproductive medicine perspective. Due to this high-risk profile, the rarity of BC in young age and the limited number of patients who might actually have opted for FP, these women must be offered timely and multidisciplinary counseling in highly specialized centers.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
Bland KI, Menck HR, Scott-Conner CE et al (1998) The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 83:1262–1273
Martin J, Hamilton B, Ventura S et al. Births: Final data for 2009. In National vital statistics reports. Hyattsville, MD: National Center for Health Statistics 2011
Martinez GM, Chandra A, Abma JC et al (2002) Fertility, contraception, and fatherhood: data on men and women from cycle 6 of the 2002 National Survey of Family Growth. Vital Health Stat 23:1–142
Schover LR, Rybicki LA, Martin BA, Bringelsen KA (1999) Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer 86:697–709
Canada AL, Schover LR (2012) The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 21:134–143
Ethics Committee of the American Society for Reproductive Medicine (2005) Fertility preservation and reproduction in cancer patients. Fertil Steril 83: 1622–1628
Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931
Lawrenz B, Jauckus J, Kupka MS et al (2011) Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet 283:651–656
Forman EJ, Anders CK, Behera MA (2010) A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril 94:1652–1656
Oktay K, Buyuk E, Davis O et al (2003) Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Human Reprod 18:90–95
Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11:422–434
von Wolff M, Donnez J, Hovatta O et al (2009) Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy–a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547–1553
Dittrich R, Lotz L, Keck G et al (2012) Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 97:387–390
de Ziegler D, Streuli I, Vasilopoulos I et al (2010) Cancer and fecundity issues mandate a multidisciplinary approach. Fertil Steril 93:691–696
Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology (2011) 2009 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta: US Department of Health and Human Services. Available at: http://www.cdc.gov/art/ART2009/PDF/ART_2009_Full.pdf. Accessed 21 March, 2012
Friedler S, Koc O, Gidoni Y et al (2012) Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 97:125–133
Tschudin S, Bunting L, Abraham J et al (2010) Correlates of fertility issues in an internet survey of cancer survivors. J Psychosom Obstet Gynaecol 31:150–157
Azim A, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26:2630–2635
Barron TI, Connolly R, Bennett K et al (2007) Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109:832–839
Guth U, Myrick ME, Kilic N et al (2012) Compliance and persistence of endocrine adjuvant breast cancer therapy. Breast Cancer Res Treat 131:491–499
Hershman DL, Kushi LH, Shao T et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28:4120–4128
Partridge AH, LaFountain A, Mayer E et al (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556–562
Compas BE, Stoll MF, Thomsen AH et al (1999) Adjustment to breast cancer: age-related differences in coping and emotional distress. Breast Cancer Res Treat 54:195–203
Ganz PA, Schag CC, Heinrich RL (1985) The psychosocial impact of cancer on the elderly: a comparison with younger patients. J Am Geriatr Soc 33:429–435
Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174–4183
Kim J, Oktay K, Gracia C et al (2012) Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril 97:671–676
Lee S, Ozkavukcu S, Heytens E et al (2010) Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 28:4683–4686
Thewes B, Meiser B, Rickard J, Friedlander M (2003) The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology 12:500–511
Tschudin S, Bitzer J (2009) Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update 15:587–597
Pagani O, Partridge A, Korde L et al (2011) Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 129:309–317
Conflict of interest
The authors declare that there are no financial or personal relationships with other people or organizations that could inappropriately influence the work reported or the conclusions, implications, or opinions stated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moffat, R., de Geyter, C., Myrick, M.E. et al. Young women with breast cancer: how many are actually candidates for fertility preservation?. Arch Gynecol Obstet 286, 1521–1527 (2012). https://doi.org/10.1007/s00404-012-2457-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2457-5